These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24507586)

  • 41. Paraoxonase activity following exercise-based cardiac rehabilitation program.
    Goldhammer E; Ben-Sira D; Zaid G; Biniamini Y; Maor I; Lanir A; Sagiv M
    J Cardiopulm Rehabil Prev; 2007; 27(3):151-4. PubMed ID: 17558196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of cardiac rehabilitation on fibrinolysis in patients with coronary artery disease.
    Anomasiri W; Thongthawee B
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S242-8. PubMed ID: 16623036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heart disease in women.
    Giardina EG
    Int J Fertil Womens Med; 2000; 45(6):350-7. PubMed ID: 11140544
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of adverse outcomes after contemporary percutaneous coronary intervention in women versus men with acute coronary syndrome.
    Pendyala LK; Torguson R; Loh JP; Kitabata H; Minha S; Badr S; Dvir D; Barbash IM; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2013 Apr; 111(8):1092-8. PubMed ID: 23352262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of depressive and anxiety symptoms in the evaluation of cardiac rehabilitation efficacy after coronary artery bypass grafting surgery.
    Szczepanska-Gieracha J; Morka J; Kowalska J; Kustrzycki W; Rymaszewska J
    Eur J Cardiothorac Surg; 2012 Nov; 42(5):e108-14. PubMed ID: 22906598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac Rehabilitation for Women.
    Bittner V
    Adv Exp Med Biol; 2018; 1065():565-577. PubMed ID: 30051407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benefits of Cardiac Rehabilitation in Coronary Artery Disease: DOES WEIGHT MATTER?
    Braga M; Nascimento H; Pinto R; Araújo P; Nunes A; Rodrigues J; Araújo V; Parada-Pereira F; Maciel MJ; Rocha A
    J Cardiopulm Rehabil Prev; 2019 Nov; 39(6):386-390. PubMed ID: 31688510
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Predictors of changes in functional capacity on a cardiac rehabilitation program].
    Branco CF; Viamonte S; Matos C; Magalhães S; Cunha I; Barreira A; Fernandes P; Torres S
    Rev Port Cardiol; 2016 Apr; 35(4):215-24. PubMed ID: 27006062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac rehabilitation and improvement of chronotropic incompetence: Is it the exercise or just the beta blockers?
    Pimenta T; Rocha JA
    Rev Port Cardiol (Engl Ed); 2021 Dec; 40(12):947-953. PubMed ID: 34922702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulating effect of cardiac rehabilitation on autonomic nervous system function in patients with coronary artery disease.
    Rio P; Pereira-Da-Silva T; Abreu A; Filipe C; Soares R; Portugal G; Alves T; Silva S; Mimoso I; Cruz Ferreira R
    Acta Cardiol; 2016; 71(6):717-723. PubMed ID: 27920460
    [No Abstract]   [Full Text] [Related]  

  • 53. [Causes of death in woman, between heart and cancer].
    Schaller M; Grira M; Keta A; Spechbach H
    Rev Med Suisse; 2015 Sep; 11(487):1755-6, 1758-60. PubMed ID: 26591789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Evaluation of the efficacy of a psychological intervention program in a Cardiac Rehabilitation Unit after acute coronary syndrome].
    Pintor Reverte R; Chabbar Boudet MC; Valls Lázaro E; Albarrán Martín C; Untoria Agustín C; Garza Benito F
    J Healthc Qual Res; 2021; 36(5):286-293. PubMed ID: 34147411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatment.
    Araujo LF; de Matos Soeiro A; Fernandes JL; Pesaro AE; Serrano CV
    Vasc Health Risk Manag; 2006; 2(4):465-75. PubMed ID: 17323601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clarifying the Concept of Depression in Women With Coronary Heart Disease.
    Buckland S; Pozehl B; Yates B
    ANS Adv Nurs Sci; 2019; 42(4):E24-E37. PubMed ID: 30864985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Why women need to sweat: the benefits of cardiac rehabilitation.
    Barron L; Schnautz LS
    Crit Care Nurs Clin North Am; 2008 Sep; 20(3):351-7. PubMed ID: 18644519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparing the effects of a cardiac rehabilitation program on functional capacity of obese and non-obese women with coronary artery disease.
    Sadeghi M; Esteki Ghashghaei F; Rouhafza H
    ARYA Atheroscler; 2012; 8(2):55-8. PubMed ID: 23056103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is there any difference between non-obese male and female in response to cardiac rehabilitation programs?
    Sadeghi M; Ghashghaei FE; Rabiei K; Roohafza H; Afshar H
    J Res Med Sci; 2012 Aug; 17(8):787-91. PubMed ID: 23798948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Women's compliance with cardiac rehabilitation programs.
    Ginzel AR
    Prog Cardiovasc Nurs; 1996; 11(1):30-5. PubMed ID: 8657707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.